Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Thrombotic thrombocytopenic purpura with unusual 33 recurrences: a case report.

Boctor FN, Chiosea I, Bradley T.

Ann Clin Lab Sci. 2013 Winter;43(1):91-3.

PMID:
23462612
[PubMed - indexed for MEDLINE]
2.

Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).

Ahmad A, Aggarwal A, Sharma D, Dave HP, Kinsella V, Rick ME, Schechter GP.

Am J Hematol. 2004 Oct;77(2):171-6.

PMID:
15389904
[PubMed - indexed for MEDLINE]
3.

Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.

Furlan M, Lämmle B.

Best Pract Res Clin Haematol. 2001 Jun;14(2):437-54. Review.

PMID:
11686108
[PubMed - indexed for MEDLINE]
4.

Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura.

Furlan M, Robles R, Solenthaler M, Lämmle B.

Blood. 1998 Apr 15;91(8):2839-46.

PMID:
9531594
[PubMed - indexed for MEDLINE]
Free Article
5.

ADAMTS-13 regulates platelet adhesion under flow. A new method for differentiation between inherited and acquired thrombotic thrombocytopenic purpura.

Shenkman B, Budde U, Angerhaus D, Lubetsky A, Savion N, Seligsohn U, Varon D.

Thromb Haemost. 2006 Aug;96(2):160-6.

PMID:
16894459
[PubMed - indexed for MEDLINE]
6.

Thrombotic thrombocytopenic purpura.

Lämmle B, Kremer Hovinga JA, Alberio L.

J Thromb Haemost. 2005 Aug;3(8):1663-75. Review.

PMID:
16102032
[PubMed - indexed for MEDLINE]
7.

Thrombotic thrombocytopenic purpura presenting with pathologic fracture: a case report.

Berber I, Erkurt MA, Kuku I, Kaya E, Unlu S, Ertem K, Nizam I.

Transfus Apher Sci. 2014 Jul 28. pii: S1473-0502(14)00130-X. doi: 10.1016/j.transci.2014.05.003. [Epub ahead of print]

PMID:
25113918
[PubMed - as supplied by publisher]
8.

Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.

Tsai HM.

J Mol Med (Berl). 2002 Oct;80(10):639-47. Epub 2002 Sep 5. Review.

PMID:
12395148
[PubMed - indexed for MEDLINE]
9.

A case of severe ADAMTS13 deficiency presenting as thrombotic thrombocytopenic purpura in pregnancy.

Nikolaou M, Karakantza M, Adonakis G, Theodorou G, Zoumbos N, Decavalas G.

Med Pregl. 2012 Sep-Oct;65(9-10):436-9.

PMID:
23214340
[PubMed - indexed for MEDLINE]
10.

Thrombotic thrombocytopenic purpura and anti-thrombotic therapy targeted to von Willebrand factor.

Zhou Z, Dong JF.

Curr Vasc Pharmacol. 2012 Nov;10(6):762-6. Review.

PMID:
22022775
[PubMed - indexed for MEDLINE]
11.

von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.

Moake JL.

Semin Hematol. 2004 Jan;41(1):4-14. Review.

PMID:
14727254
[PubMed - indexed for MEDLINE]
12.

Recent advances in thrombotic thrombocytopenic purpura.

Sadler JE, Moake JL, Miyata T, George JN.

Hematology Am Soc Hematol Educ Program. 2004:407-23. Review.

PMID:
15561695
[PubMed - indexed for MEDLINE]
Free Article
13.

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lämmle B.

N Engl J Med. 1998 Nov 26;339(22):1578-84.

PMID:
9828245
[PubMed - indexed for MEDLINE]
Free Article
14.

ADAMTS-13 may not predict disease or outcome in patients with Thrombotic Thrombocytopenic Purpura.

Rock G, Clark WF, Anderson D, Benny B, Sutton D, Leblond P, Sternbach M, Sontrop J; Members of the Canadian Apheresis Group.

Thromb Res. 2013 Apr;131(4):308-12. doi: 10.1016/j.thromres.2013.01.024. Epub 2013 Feb 11.

PMID:
23411128
[PubMed - indexed for MEDLINE]
15.

Inhibition of von Willebrand factor-platelet glycoprotein Ib interaction prevents and reverses symptoms of acute acquired thrombotic thrombocytopenic purpura in baboons.

Feys HB, Roodt J, Vandeputte N, Pareyn I, Mottl H, Hou S, Lamprecht S, Van Rensburg WJ, Deckmyn H, Vanhoorelbeke K.

Blood. 2012 Oct 25;120(17):3611-4. doi: 10.1182/blood-2012-04-421248. Epub 2012 Jul 31.

PMID:
22855603
[PubMed - indexed for MEDLINE]
Free Article
16.

Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.

Furlan M.

Expert Rev Cardiovasc Ther. 2003 Jul;1(2):243-55. Review.

PMID:
15030284
[PubMed - indexed for MEDLINE]
17.

The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine.

Böhm M, Betz C, Miesbach W, Krause M, von Auer C, Geiger H, Scharrer I.

Br J Haematol. 2005 Jun;129(5):644-52.

PMID:
15916687
[PubMed - indexed for MEDLINE]
18.

Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.

Zhou Z, Nguyen TC, Guchhait P, Dong JF.

Semin Thromb Hemost. 2010 Feb;36(1):71-81. doi: 10.1055/s-0030-1248726. Epub 2010 Apr 13. Review.

PMID:
20391298
[PubMed - indexed for MEDLINE]
19.

[New marker in thrombotic thrombocytopenic purpura].

Gøtze JP, Hillarp A, Lindblom A, Björk P, Strandberg K, Nielsen LB.

Ugeskr Laeger. 2008 Aug 11;170(33):2446-9. Review. Danish.

PMID:
18761827
[PubMed - indexed for MEDLINE]
20.

Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond.

Lian EC.

Semin Thromb Hemost. 2005 Dec;31(6):625-32. Review.

PMID:
16388413
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk